Therapeutic Effects of Neurofeedback in Anorexia Nervosa
Therapeutic Effects of Alpha-neurofeedback in the Treatment of Anorexia Nervosa
1 other identifier
interventional
12
0 countries
N/A
Brief Summary
The purpose of this study is to determine whether neurofeedback training can significantly reduce the symptoms of anorexia nervosa (AN) with focus on changes in personality and psychological well-being. The primary aims of this study include:
- 1.To examine whether AN patients are able to control their alpha-activity through neurofeedback.
- 2.To examine the effects of neurofeedback on symptomatology and personality variables in AN patients.
- 3.To examine the long-term effects of neurofeedback in the treatment of AN.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_1
Started Oct 2010
Longer than P75 for phase_1
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2010
CompletedFirst Submitted
Initial submission to the registry
July 7, 2011
CompletedFirst Posted
Study publicly available on registry
July 11, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2014
CompletedMarch 11, 2015
March 1, 2015
4.1 years
July 7, 2011
March 10, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
brain activity in the alpha band
measuring selected variables pre/posttraining and follow-up and on 10 points of measurement (10 sessions neurofeedback)
10 sessions neurofeedback
Study Arms (1)
neurofeedback, alpha power
EXPERIMENTALInterventions
training of individual alpha frequency, 10 sessions, each 15 min
Eligibility Criteria
You may qualify if:
- anorexia nervosa diagnosed by ICD-10
You may not qualify if:
- epilepsy or other brain organic diseases
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nina Lackner, Mag.
Department of Psychology, Karl-Franzens-University Graz
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 7, 2011
First Posted
July 11, 2011
Study Start
October 1, 2010
Primary Completion
November 1, 2014
Study Completion
November 1, 2014
Last Updated
March 11, 2015
Record last verified: 2015-03